Rationale and design features of a clinical trial examining the effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT). SCAT Investigators.

Teo, K K; Burton, J R; Buller, C; Plante, S; Yokoyama, S; Montague, T J

Teo, K K; Burton, J R; Buller, C; Plante, S; Yokoyama, S; Montague, T J.

Affiliation

Teo KK; Division of Cardiology, University of Alberta Hospitals, Edmonton. kkt@tachy@uah.ualberta.ca

Can J Cardiol ; 13(6): 591-9, 1997 Jun.

Article in En | MEDLINE | ID: mdl-9215232

Subject(s)

Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Anticholesteremic Agents/therapeutic use; Coronary Artery Disease/drug therapy; Enalapril/therapeutic use; Lovastatin/analogs & derivatives; Aged; Cholesterol/blood; Coronary Angiography; Coronary Artery Disease/blood; Coronary Artery Disease/diagnostic imaging; Coronary Artery Disease/physiopathology; Disease Progression; Double-Blind Method; Female; Humans; Lovastatin/therapeutic use; Male; Middle Aged; Research Design; Simvastatin; Treatment Outcome; Ventricular Function, Left

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Angiotensin-Converting Enzyme Inhibitors / Lovastatin / Enalapril / Anticholesteremic Agents Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Can J Cardiol Journal subject: CARDIOLOGIA Year: 1997 Document type: Article Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links